A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P. Mohammad, Ryan G. Kruger, Kimberly N. Smitheman et al.|Cancer Cell|2015Cited by 518
Improved measurement of disease progression in people living with early Parkinson’s disease using digital health technologiesMatthew Czech, Joshua D. Cosman, Michelle Crouthamel et al.|Communications Medicine|2024Cited by 19